Exclusive

Publication

Byline

Singapore Clinical Trial: A Phase 2b/Phase 3, randomized, double-blind, placebo-controlled, multicenter study, to investigate the efficacy and safety of lunsekimig in adult participants with inadequately controlled chronic obstructive pulmonary disease (COPD) characterized by an eosinophilic phenotype

Singapore, March 31 -- The Health Sciences Authority received information related to the study titled 'A Phase 2b/Phase 3, randomized, double-blind, placebo-controlled, multicenter study, to investiga... Read More


Singapore Clinical Trial: A Phase 2b/Phase 3, randomized, double-blind, placebo-controlled, multicenter study, to investigate the efficacy and safety of lunsekimig in adult participants with inadequately controlled chronic obstructive pulmonary disease (COPD) characterized by an eosinophilic phenotype

Singapore, March 31 -- The Health Sciences Authority received information related to the study titled 'A Phase 2b/Phase 3, randomized, double-blind, placebo-controlled, multicenter study, to investiga... Read More


Singapore Clinical Trial: A Phase 1, Randomized, Placebo-Controlled, Single Ascending Dose-Escalation Study to Investigate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of LY4167586 in Participants with Obesity or Overweight who are Otherwise Healthy.

Singapore, March 31 -- The Health Sciences Authority received information related to the study titled 'A Phase 1, Randomized, Placebo-Controlled, Single Ascending Dose-Escalation Study to Investigate ... Read More


'Redemption is here': Dino Melaye explains how ADC will defeat Tinubu in 2027

Nigeria, March 31 -- A former Kogi West senator, Dino Melaye, has argued that the opposition African Democratic Congress (ADC) will defeat President Bola Tinubu in the 2027 presidential election in Ni... Read More


Mercedes-Benz CLA Electric set to launch in India on April 24: expected price, features and battery pack

India, March 31 -- German automaker Mercedes-Benz is set to launch its entry-level electric sedan, the CLA electric, in India on April 24. This is the first time that the CLA will be launched in an el... Read More


Israel Passes Death Penalty Law for Palestinians

Afghanistan, March 31 -- Israel's parliament has approved a controversial new law that imposes the death penalty by default on Palestinians convicted of deadly attacks, drawing sharp international cri... Read More


Bhumi: వయసు పెరుగుతోంది, అందుకే నా శరీరంపై ఫోకస్ పెట్టాను.. వెయిట్ లాస్ ట్రోల్స్‌పై స్టార్ హీరోయిన్ భూమి కామెంట్స్

భారతదేశం, మార్చి 31 -- బాలీవుడ్ వెర్సటైల్ హీరోయిన్ భూమి పెడ్నేకర్ తన కెరీర్ ఆరంభం నుంచి బాడీ ట్రాన్స్‌ఫార్మేషన్ విషయంలో వార్తల్లో నిలుస్తూనే ఉన్నారు. తొలి సినిమా 'దమ్ లగా కే హయిషా' కోసం భారీగా బరువు ప... Read More


Singapore Clinical Trial: ROSETTA CRC-203: A Blinded, Randomized Phase 2/3 Study of Pumitamig in Combination with Chemotherapy Versus Bevacizumab in Combination with Chemotherapy in Participants with Previously Untreated, Unresectable, or Metastatic Colorectal Cancer

Singapore, March 31 -- The Health Sciences Authority received information related to the study titled 'ROSETTA CRC-203: A Blinded, Randomized Phase 2/3 Study of Pumitamig in Combination with Chemother... Read More


Singapore Clinical Trial: A Phase 3, Multicenter, Randomized, Double-Blinded, Placebo-Controlled Study to Evaluate the Safety and Efficacy of L606 (Treprostinil Liposome Inhalation Suspension) in Participants with Pulmonary Hypertension Associated with Interstitial Lung Disease (WHO Group 3)

Singapore, March 31 -- The Health Sciences Authority received information related to the study titled 'A Phase 3, Multicenter, Randomized, Double-Blinded, Placebo-Controlled Study to Evaluate the Safe... Read More


Singapore Clinical Trial: A Phase III, Randomized, Open-Label, Multicenter, Global Study of Puxitatug Samrotecan (AZD8205) Monotherapy versus Physician’s Choice of Chemotherapy in Participants with B7-H4-Selected Advanced/Metastatic Endometrial Cancer Who Progressed On or After Platinum-Based Chemotherapy and Anti-PD-1/Anti-PD-L1 Therapy (BLUESTAR-Endometrial01)

Singapore, March 31 -- The Health Sciences Authority received information related to the study titled 'A Phase III, Randomized, Open-Label, Multicenter, Global Study of Puxitatug Samrotecan (AZD8205) ... Read More